PHIO PHARMACEUTICALS CORP's ticker is and the CUSIP is 71880W903. A total of 1 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 1,100 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1,100 | +450.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | -80.0% | 0.00% | – |
| Q4 2021 | $1,000 | -93.3% | 1,000 | -85.3% | 0.00% | – |
| Q3 2021 | $15,000 | 0.0% | 6,800 | 0.0% | 0.00% | – |
| Q2 2021 | $15,000 | -83.5% | 6,800 | +1882.5% | 0.00% | – |
| Q1 2021 | $91,000 | – | 343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |